Abstract:The conversion of native soluble proteins into insoluble amyloid fibrils that are rich in cross β-sheet structure is associated with a variety of neurodegenerative diseases. It has recently become apparent that smaller oligomers formed during the early stages of amyloid fibril formation may be primarily responsible for the toxicity in amyloid diseases. Traditional ensemble techniques have limitations in characterization of oligomers due to the metastable and heterogeneous nature of these prefibrillar species. Single molecule fluorescence spectroscopy allows the conformational dynamics of individual biomolecules to be investigated, revealing properties that may be averaged in the ensemble experiment. It is therefore extremely powerful for identification and characterization of the low-populated, heterogeneous and transient species formed during fibril assembly. Combining single molecule fluorescence with kinetic modeling can provide quantitative information regarding the microscopic steps in amyloid formation. Here we have applied single molecule fluorescence resonance energy transfer to investigate in detail the intermolecular assembly and aggregation process of the yeast prion protein Ure2. Oligomerization during the initial lag phase was observed, and two types of Ure2 oligomers with different assembly modes were identified. Furthermore, using theoretical analysis combined with single molecule and ensemble kinetic data, we describe the formation and depletion pathway of oligomers, and propose a multi-step mechanism for Ure2 fibril formation, in which initial oligomerization is followed by conformational conversion to β-sheet containing oligomers that are then able to grow to form mature amyloid fibrils. We also show directly that secondary nuclei do not form, and that fragmentation is therefore responsible for the autocatalytic behavior of Ure2, in contrast to the mechanism of the amyloid formation of Aβ peptide. These results shed light on the potential origin of differences in cytotoxicity between functional and disease-related amyloids.

The Effect of Mechanical Shocks on the Initial Aggregation Behavior of Yeast Prion Protein Sup35NM.

Quantitative Study of the Oligomerization of Yeast Prion Sup35NM Proteins.

Real-Time Characterization of Cell Membrane Disruption by Α-Synuclein Oligomers in Live SH-SY5Y Neuroblastoma Cells.

Oligomerization of Yeast Prion Sup35NM

Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Insight into Sup35(7-13) Misfolding and Interactions Using Molecular Dynamics Simulation

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

Molecular Dynamics Simulations on the Oligomer-Formation Process of the GNNQQNY Peptide from Yeast Prion Protein Sup35.

Revealing the Mechanism of Amyloid Fibril Formation by Combined Single Molecule FRET and Kinetic Modeling

Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35

Experimental and Theoretical Insights into the Inhibition Mechanism of Prion Fibrillation by Resveratrol and Its Derivatives

Proteins in Aggregates Functionally Impact Multiple Neurodegenerative Disease Models by Forming Proteasome-Blocking Complexes

Electron Microscopy Study of the Structure of the Sup35 Prion from Yeast Saccharomyces cerevisiae

Molecular chaperones and the assembly of the prion Sup35p, an in vitro study

Molecular Dynamics Simulations of Alzheimer Abeta40 Elongation and Lateral Association.

The Contrasting Effect of Macromolecular Crowding on Amyloid Fibril Formation

Effect Of Amino Acid Sequence Rearrangment On Prion Aggregation: Molecular Dynamics Simulations Of An Amyloid-Forming Peptide From The Yeast Prion Sup35p

Modulation of Aggregation and Structural Polymorphisms of Β-Amyloid Fibrils in Cellular Environments by Pyroglutamate-3 Variant Cross-Seeding.

Effects of the A117v Mutation on the Folding and Aggregation of Palindromic Sequences (Prp113-120) in Prion: Insights from Replica Exchange Molecular Dynamics Simulations

A variational model for oligomer-formation process of GNNQQNY peptide from yeast prion protein Sup35.

Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils